Riverhead Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,384
| Closed | -$85K | – | 1599 |
|
|
2018
Q1 | $85K | Buy |
4,384
+100
| +2% | +$1.94K | ﹤0.01% | 1384 |
|
|
2017
Q4 | $71K | Buy |
4,284
+900
| +27% | +$14.9K | ﹤0.01% | 1426 |
|
|
2017
Q3 | $69K | Buy |
3,384
+321
| +10% | +$6.55K | ﹤0.01% | 1387 |
|
|
2017
Q2 | $49K | Buy |
3,063
+1,463
| +91% | +$23.4K | ﹤0.01% | 1416 |
|
|
2017
Q1 | $20K | Buy |
1,600
+200
| +14% | +$2.5K | ﹤0.01% | 1469 |
|
|
2016
Q4 | $19K | Hold |
1,400
| – | – | ﹤0.01% | 1429 |
|
|
2016
Q3 | $33K | Sell |
1,400
-2,516
| -64% | -$59.3K | ﹤0.01% | 1296 |
|
|
2016
Q2 | $364K | Sell |
3,916
-7,984
| -67% | -$742K | 0.01% | 684 |
|
|
2016
Q1 | $381K | Sell |
11,900
-1,700
| -13% | -$54.4K | 0.01% | 996 |
|
|
2015
Q4 | $582K | Buy |
13,600
+9,900
| +268% | +$424K | 0.01% | 829 |
|
|
2015
Q3 | $130K | Buy |
+3,700
| New | +$130K | ﹤0.01% | 931 |
|